Reflow Medical

Reflow Medical is a cardiovascular medical device innovator that leverages deep physician collaboration to design and commercialize interventional tools. The company's core philosophy, the 'Innovation Algorithm,' creates a continuous feedback loop between clinicians and engineers to address specific procedural challenges in peripheral and coronary artery disease. With a portfolio including the Spur, coraCatheters, Wingman, and speX product lines, Reflow targets the large and growing market for minimally invasive vascular interventions. As a private company, it operates with a commercial-stage revenue model, actively marketing its devices to interventionalists globally.

The 'Innovation Algorithm' – a physician-centric, iterative R&D process that partners engineers directly with clinicians to identify unmet needs, prototype devices, and refine them based on clinical feedback and data.

Reflow operates in the highly competitive cardiovascular device market, competing against giants like Boston Scientific, Medtronic, and Abbott, as well as numerous specialized private companies. Its differentiation is its intense physician-co-development model, aiming to create best-in-class tools for specific procedural niches rather than offering broad portfolios. Success depends on outperforming in areas like crossing chronic total occlusions and catheter deliverability.